This topic contains a solution. Click here to go to the answer

Author Question: Compare and contrast the risk of complication, comorbidity or mortality with the first element of ... (Read 27 times)

burchfield96

  • Hero Member
  • *****
  • Posts: 610
Compare and contrast the risk of complication, comorbidity or mortality with the first element of medical decision making, the number of diagnosis(es) and/or management option(s). Be specific.
 
  What will be an ideal response?

Question 2

Compare and contrast the risk of complication, comorbidity or mortality for the diagnostic procedure ordered with the amount and/or complexity of data to be reviewed (the second element of medical decision making). Be specific.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ddddd

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

The answer should include:
 A brief review of the definition for the number of diagnosis(es) and/or management option(s), which should identify
i. The physician's familiarity with the presenting problem and
ii. Any potential (or current) management options for the treatment of this presenting problem.
 However, the risk of complications, comorbidity or mortality identifies just how much risk this presenting problem or management option poses to the health of the patient. This requires a higher level of specificity for, not only the identification of the presenting problem, but the clinical impact the presenting problem has had, is having, or will continue to have on the patient's health.
 The number of diagnosis(es) and/or management options simply identifies the possible, probable or rule out diagnosis, which leaves room for definitive clarification of the presenting problem.
 However, the risk of complications, comorbidity or mortality identifies the specific risk posed by this presenting problem, the diagnostic procedure ordered to diagnose definitively the presenting problem, and the management option selected to treat or manage the presenting problem.

Answer to Question 2

Answer should include:
 A brief definition of the amount and/or complexity of data to be reviewed, which should identify
i. The six different documentation guidelines that identify the methods of data collection and review.
 However, the risk of complication, comorbidity, or mortality for the diagnostic procedure ordered specifically identify the risk this (these) ordered diagnostic procedures pose to the health of the patient.
 The amount and/or complexity of data to be reviewed includes the physician involvement in the collection of and review of data, while the risk of complication, comorbidity, or mortality for the diagnostic procedure ordered identifies the risk posed to the health of the patient.




burchfield96

  • Member
  • Posts: 610
Reply 2 on: Jun 27, 2018
Wow, this really help


fatboyy09

  • Member
  • Posts: 358
Reply 3 on: Yesterday
Gracias!

 

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

For a complete list of videos, visit our video library